George B. Breen
U.S. Department of Justice Announces Interagency Task Force to Combat COVID-19 Relief Fraud
Administrative and Regulatory ·
Defendant Aventis Pharma Awarded Over $17.2 Million in Attorneys’ Fees in False Claims Act Case
Health Care and Life Sciences ·
U.S. Department of Justice Announces First Charges Brought Under the Accelerated and Advance Payment Program
Health Care and Life Sciences ·
U.S. Department of Justice Reports on Heightened Enforcement Activities Against COVID-19 Related Fraud
Administrative and Regulatory ·